LUBIPROSTONE 8 MCG CAPSULE

What it is

LUBIPROSTONE 8 MCG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lubiprostone.

FDA gives its dosage form as “capsule, gelatin coated” and “capsule” and its route as oral.

FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Par Health USA, LLC, Teva Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Chloride Channel Activator.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 9 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $16.96 for 30 capsules (30 × $0.56517 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 capsules · NADAC explanation codes

The 9 labelers

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name lubiprostone with LUBIPROSTONE 8 MCG CAPSULE.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $0.56517 per EA filed.

Of the 3 other products in FDA’s Chloride Channel Activator class priced per EA, 3 have a higher middle NADAC price and 0 a lower one. The one in the middle is AMITIZA 24 MCG CAPSULE, at $6.44889 per EA filed (eff. 2026-04-22).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $50.03 for 30 capsules, at an average of $1.66781 per EA in 2024 (2024-01-01 to 2024-12-31) for “Lubiprostone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 440,018 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.